Stubbe BE, Madsen PH, Larsen AC, Krarup HB, et al. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma. Pancreatology 2023 May 12:S1424-3903(23)00140-0. doi: 10.1016/j.pan.2023.
PMID: 37230892